ZNF367 inhibits cancer progression and is targeted by miR-195

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Jain, Meenu ^a   Zhang, Lisa ^a   Boufraqech, Myriem ^a   Liu Chittenden, Yi ^a   Bussey, Kimberly ^b   Demeure, Michael J ^b   Wu, Xiaolin ^c   Su, Ling ^c   Pacak, Karel ^d   Stratakis, Constantine A ^d   Kebebew, Electron ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Translational Genomic Research Institute   (United States)

^c SAIC FREDERICK INC   (United States)

^d EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA3 INTEGRIN; MICRORNA; MICRORNA 195; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; ZINC FINGER PROTEIN 367; KRUPPEL LIKE FACTOR; MIRN195 MICRORNA, HUMAN; ZNF367 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BENIGN TUMOR; CANCER CELL LINE; CANCER GROWTH; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE; GENE CONTROL; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENE INTERACTION; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; ITGA3 GENE; MOUSE; NONHUMAN; PARAGANGLIOMA; PHEOCHROMOCYTOMA; RNA ANALYSIS; THYROID CANCER; ZNF367 GENE; ADRENAL CORTEX CARCINOMA; ADRENAL TUMOR; ANIMAL; DISEASE COURSE; ENDOCRINE TUMOR; GENETICS; METABOLISM; PATHOLOGY; THYROID GLAND; THYROID TUMOR; TUMOR CELL LINE; TUMOR INVASION;

ADRENAL GLAND NEOPLASMS; ADRENOCORTICAL CARCINOMA; ANIMALS; CELL LINE, TUMOR; DISEASE PROGRESSION; ENDOCRINE GLAND NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MICE; MICRORNAS; NEOPLASM INVASIVENESS; PHEOCHROMOCYTOMA; THYROID GLAND; THYROID NEOPLASMS;

EID: 84904670520     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101423     Document Type: Article

References (27)

1. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674.
2. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, et al. (2002) Mutations of the BRAF gene in human cancer. Nature 417: 949-954. (Pubitemid 34716871)
3. Xing M, Alzahrani AS, Carson KA, Viola D, Elisei R, et al. (2013) Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer. JAMA 309: 1493-1501.
4. Pasini B, Stratakis CA (2009) SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma-paraganglioma syndromes. J Intern Med 266: 19-42.
5. Xekouki P, Pacak K, Almeida M, Wassif CA, Rustin P, et al. (2012) Succinate dehydrogenase (SDH) D subunit (SDHD) inactivation in a growth-hormone-producing pituitary tumor: a new association for SDH? J Clin Endocrinol Metab 97: E357-366.
6. Asano H, Murate T, Naoe T, Saito H, Stamatoyannopoulos G (2004) Molecular cloning and characterization of ZFF29: a protein containing a unique Cys2His2 zinc-finger motif. Biochem J 384: 647-653. (Pubitemid 40018979)
7. Gilligan P, Brenner S, Venkatesh B (2002) Fugu and human sequence comparison identifies novel human genes and conserved non-coding sequences. Gene 294: 35-44. (Pubitemid 35291011)
8. Seyhan AA, Varadarajan U, Choe S, Liu W, Ryan TE (2012) A genome-wide RNAi screen identifies novel targets of neratinib resistance leading to identification of potential drug resistant genetic markers. Mol Biosyst 8: 1553-1570.
9. Wang T, Wang XG, Xu JH, Wu XP, Qiu HL, et al. (2012) Overexpression of the human ZNF300 gene enhances growth and metastasis of cancer cells through activating NF-kB pathway. J Cell Mol Med 16: 1134-1145.
10. Duan Z, Choy E, Harmon D, Yang C, Ryu K, et al. (2009) ZNF93 increases resistance to ET-743 (Trabectedin; Yondelis) and PM00104 (Zalypsis) in human cancer cell lines. PLoS One 4: e6967.
11. Sachs N, Secades P, van Hulst L, Kreft M, Song JY, et al. (2012) Loss of integrin alpha3 prevents skin tumor formation by promoting epidermal turnover and depletion of slow-cycling cells. Proc Natl Acad Sci U S A 109: 21468-21473.
12. Gerdin AK (2010) The Sanger Mouse Genetics Programme: high throughput characterisation of knockout mice. Acta Ophthalmologica 88.
13. Rink L, Skorobogatko Y, Kossenkov AV, Belinsky MG, Pajak T, et al. (2009) Gene expression signatures and response to imatinib mesylate in gastrointestinal stromal tumor. Mol Cancer Ther 8: 2172-2182.
14. Rossi M, Abbondanza C, D'Arcangelo A, Gazzerro P, Medici N, et al. (2004) The Zn-finger domain of RIZ protein promotes MCF-7 cell proliferation. Cancer Lett 215: 229-237. (Pubitemid 39370041)
15. Kuramoto K, Uesaka T, Kimura A, Kobayashi M, Watanabe H, et al. (2000) ZK7, a novel zinc finger gene, is induced by vascular endothelial growth factor and inhibits apoptotic death in hematopoietic cells. Cancer Res 60: 425-430. (Pubitemid 30070772)
16. Finnerty JR, Wang WX, Hebert SS, Wilfred BR, Mao G, et al. (2010) The miR-15/107 group of microRNA genes: evolutionary biology, cellular functions, and roles in human diseases. J Mol Biol 402: 491-509.
17. Ozata DM, Caramuta S, Velazquez-Fernandez D, Akcakaya P, Xie H, et al. (2011) The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma. Endocr Relat Cancer 18: 643-655.
18. Soon PS, Tacon LJ, Gill AJ, Bambach CP, Sywak MS, et al. (2009) miR-195 and miR-483-5p Identified as Predictors of Poor Prognosis in Adrenocortical Cancer. Clin Cancer Res 15: 7684-7692.
19. Akama T, Sue M, Kawashima A, Wu H, Tanigawa K, et al. (2012) Identification of microRNAs that mediate thyroid cell growth induced by TSH. Mol Endocrinol 26: 493-501.
20. Slaby O, Redova M, Poprach A, Nekvindova J, Iliev R, et al. (2012) Identification of MicroRNAs associated with early relapse after nephrectomy in renal cell carcinoma patients. Genes Chromosomes Cancer 51: 707-716.
21. Wang X, Wang J, Ma H, Zhang J, Zhou X (2012) Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer. Med Oncol 29: 919-927.
22. Zhang QQ, Xu H, Huang MB, Ma LM, Huang QJ, et al. (2012) MicroRNA-195 plays a tumor-suppressor role in human glioblastoma cells by targeting signaling pathways involved in cellular proliferation and invasion. Neuro Oncol 14: 278-287.
23. Li D, Zhao Y, Liu C, Chen X, Qi Y, et al. (2011) Analysis of MiR-195 and MiR-497 expression, regulation and role in breast cancer. Clin Cancer Res 17: 1722-1730.
24. Furuta M, Kozaki K, Tanimoto K, Tanaka S, Arii S, et al. (2013) The tumor-suppressive miR-497-195 cluster targets multiple cell-cycle regulators in hepatocellular carcinoma. PLoS One 8: e60155.
25. Mao JH, Zhou RP, Peng AF, Liu ZL, Huang SH, et al. (2012) microRNA-195 suppresses osteosarcoma cell invasion and migration in vitro by targeting FASN. Oncol Lett 4: 1125-1129.
26. Bai Y, Yang W, Yang HX, Liao Q, Ye G, et al. (2012) Downregulated miR-195 detected in preeclamptic placenta affects trophoblast cell invasion via modulating ActRIIA expression. PLoS One 7: e38875.
27. Akiyama SK, Olden K, Yamada KM (1995) Fibronectin and integrins in invasion and metastasis. Cancer Metastasis Rev 14: 173-189.